Author: Christian Velten

Training employees on AI tools might miss the point; why not investing into fully AI-managed operational workflows that free people for impact.

Where to prioritize corporate AI implementation & investments? First improving operational efficiencies, or prioritizing AI use cases aligned with strategic business priorities?

Fireside chat at Dec 2025 AMCX monthly meeting on transforming customer interactions and relationships by digitizing the journey.

Dr. Christian Velten speaking at MedFIT 2025 conference, about “The empowerment of the people: digital health, self-care and the future of healthcare”.

I am already curious to pick up the thoughts of other leaders cross-industries at an Adobe rountable for senior leaders “Get Ready for 2026 & the Future – Innovation, Agentic AI & Responsible Transformation” in November 2025.

Looking forward to attend the MIT Sloan program “Artificial Intelligence: Implications for Business Strategy”.

AI is increasingly competing with pharma and healthcare industries on information and knowlegde about their products. This should not be ignored anymore.

In today’s dynamic political landscape, European pharmaceutical companies have a unique opportunity to thrive despite the challenges presented by evolving US policies. While tariffs and cost pressures may cause hesitation, this moment calls for innovation and bold strategies. Are these obstacles a chance for growth, or merely an excuse to hold back?

Dr. Christian Velten speaking at 2025 Reuters Pharma Barcelona conference about closing the feedback loop and taking action on customer feedback

A disclaimer first. I am not Swiss myself. So, I claim being a (mostly) unbiased and impartial advocate. Since late 2008, I am working in multinational Swiss-based companies. And in all of them I now and then met other non-Swiss colleagues who whispered complaints about their Swiss colleagues. Typically it is about Swiss people being perceived as being slower with business progress, too much into details, causing delayed decisions. Thereby taking some non-Swiss colleagues’ nerves. After having had the opportunity experiencing myself the “Swiss way” and its business impact for a couple of years, I need to say … that…